Boris Engels
Impact in
- Oncology top 2%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
Papers in
- Oncology 24
- CAR-T cell therapy research 23
- Immunology 18
- Immune Cell Function and Interaction 12
- T-cell and B-cell Immunology 9
- Immunotherapy and Immune Responses 8
- Co-authors
- Wolfgang Uckert (12 shared papers)Hans Wilhelm Schreiber (12 shared papers)Donald A. Rowley (5 shared papers)Thomas J. F. Blankenstein (5 shared papers)David M. Kranz (5 shared papers)Matthias Leisegang (6 shared papers)Shao‐An Xue (3 shared papers)Hans Stauß (3 shared papers)
- Journals
- Clinical Cancer Research (4 papers)Molecular Therapy (2 papers)Blood (2 papers)Cancer Research (2 papers)Gene Therapy (2 papers)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Boris Engels
30 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 69
- Oncology 1.2k
- Immunology 834
- Genetics 454
- Biotechnology 112
- Developmental Neuroscience 23
Countries citing papers authored by Boris Engels
This map shows the geographic impact of Boris Engels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boris Engels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boris Engels more than expected).
Fields of papers citing papers by Boris Engels
This network shows the impact of papers produced by Boris Engels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boris Engels. The network helps show where Boris Engels may publish in the future.
Co-authors
The 25 scholars most cited alongside Boris Engels, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 237 | |
| 2 | 2005 | 162 | |
| 3 | 2003 | 158 | |
| 4 | 2013 | 130 | |
| 5 | 2008 | 104 | |
| 6 | 2006 | 79 | |
| 7 | 2013 | 71 | |
| 8 | 2015 | 65 | |
| 9 | 2011 | 64 | |
| 10 | 2013 | 54 | |
| 11 | 2011 | 46 | |
| 12 | 2012 | 45 | |
| 13 | 2008 | 44 | |
| 14 | 2005 | 43 | |
| 15 | 2013 | 43 | |
| 16 | 2007 | 40 | |
| 17 | 2012 | 38 | |
| 18 | 2010 | 28 | |
| 19 | 2012 | 24 | |
| 20 | 2012 | 21 |
About Boris Engels
Boris Engels is a scholar working on Oncology, Immunology, Genetics, Biotechnology and Genetics, having authored 33 papers that have together received 1.6k indexed citations. Recurring topics across this work include CAR-T cell therapy research (23 papers), Immune Cell Function and Interaction (12 papers), T-cell and B-cell Immunology (9 papers), Immunotherapy and Immune Responses (8 papers), Virus-based gene therapy research (7 papers), Cancer Research and Treatments (2 papers), Viral Infectious Diseases and Gene Expression in Insects (2 papers) and Research on Leishmaniasis Studies (2 papers). The work is most often cited by research in Oncology (1.2k citations), Immunology (834 citations), Genetics (454 citations), Biotechnology (112 citations) and Developmental Neuroscience (23 citations). Boris Engels has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Wolfgang Uckert, Hans Wilhelm Schreiber, Donald A. Rowley, Thomas J. F. Blankenstein, David M. Kranz, Matthias Leisegang, Shao‐An Xue, Hans Stauß, David C. Binder and Stefano Indraccolo. Their work appears in journals such as Clinical Cancer Research, Molecular Therapy, Blood, Cancer Research and Gene Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.